Dr. Reddy's Laboratories Limited (BOM:500124)
India · Delayed Price · Currency is INR 1,274.55
+4.25 (0.33%)
At close: Feb 12, 2026
Dr. Reddy's Laboratories Market Cap
Dr. Reddy's Laboratories has a market cap or net worth of 1.06 trillion as of February 13, 2026. Its market cap has increased by 4.00% in one year.
Market Cap
1.06T
Enterprise Value
1.05T
Revenue
345.83B
Ranking
n/a
PE Ratio
18.76
Stock Price
1,274.55
Market Cap Chart
Since May 31, 1999, Dr. Reddy's Laboratories's market cap has increased from 21.00B to 1.06T, an increase of 4,952.04%. That is a compound annual growth rate of 15.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 1.06T | 0.28% |
| Dec 31, 2025 | 1.06T | -8.50% |
| Dec 31, 2024 | 1.16T | 19.80% |
| Dec 29, 2023 | 965.41B | 37.28% |
| Dec 30, 2022 | 703.23B | -13.66% |
| Dec 31, 2021 | 814.50B | -5.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.37T |
| Lupin | 1.01T |
| Abbott India | 571.48B |
| GlaxoSmithKline Pharmaceuticals | 457.53B |
| J. B. Chemicals & Pharmaceuticals | 304.50B |
| AstraZeneca Pharma India | 226.77B |
| Jubilant Pharmova | 148.72B |
| Granules India | 140.43B |